HUDDINGE, Sweden, Aug. 24, 2023 /PRNewswire/ — XNK Therapeutics AB (“XNK”) today announced that the company has entered into a research collaboration with the Karolinska University Hospital, Sweden, to evaluate the suitability of the company’s autologous natural killer (NK) cell therapy…